Inventor
PEACH ROBERT JAMES
US26 patents
⚠️ This page may combine multiple inventors who share the name “PEACH ROBERT JAMES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
20 patentsUS7358354B2Apr 15, 2008
Polynucleotides encoding BSL3
BRISTOL MYERS SQUIBB CO75 citations98
US7279567B2Oct 9, 2007
Polynucleotides-encoding B7-related polypeptide, BSL2-L165-35B
BRISTOL MYERS SQUIBB CO77 citations98
US7455835B2Nov 25, 2008
Methods for treating immune system diseases using a soluble CTLA4 molecule
BRISTOL MYERS SQUIBB CO57 citations96
US7368554B2May 6, 2008
Polynucleotides encoding BSL2v1c2-Ig
BRISTOL MYERS SQUIBB CO53 citations95
US7723479B2May 25, 2010
BSL3 polypeptides
BRISTOL MYERS SQUIBB CO36 citations94
US8354513B2Jan 15, 2013
Polynucleotides encoding BSL2vcvc-lg
BRISTOL MYERS SQUIBB CO10 citations92
US8722632B2May 13, 2014
Methods for treating Sjogrens syndrome by administering a soluble CTLA4 molecule
BRISTOL MYERS SQUIBB CO9 citations91
US7700556B2Apr 20, 2010
Methods of treatment using CTLA4 mutant molecules
BRISTOL MYERS SQUIBB CO14 citations91
US9409970B2Aug 9, 2016
Polynucleotides encoding BSL2v2c2
BRISTOL MYERS SQUIBB CO14 citations90
US9758565B2Sep 12, 2017
Methods of treatment using CTLA4 mutant molecules
BRISTOL MYERS SQUIBB CO6 citations83
US9296808B2Mar 29, 2016
Methods for treating scleroderma by administering a soluble CTLA4 molecule
BRISTOL MYERS SQUIBB CO7 citations83
US8703718B2Apr 22, 2014
Methods for treating juvenile rheumatoid arthritis by administering a soluble CTLA4 molecule
BRISTOL MYERS SQUIBB CO7 citations83
US8674076B2Mar 18, 2014
BSL2vcvc-lg polypeptides
BRISTOL MYERS SQUIBB CO3 citations73
US7807786B2Oct 5, 2010
BSL2v1c2 polypeptides
BRISTOL MYERS SQUIBB CO5 citations73
US10052360B2Aug 21, 2018
Methods for treating dermatomyositis or polymyositis by administering a soluble CTLA4 molecule
BRISTOL MYERS SQUIBB CO2 citations72
US10590183B2Mar 17, 2020
BSL2v2c2-Ig polypeptides
BRISTOL MYERS SQUIBB CO0 citations52
US10400023B2Sep 3, 2019
B7-related nucleic acids and polypeptides useful for immunomodulation
BRISTOL MYERS SQUIBB CO0 citations52
US10308702B2Jun 4, 2019
BSL2v2c2-Ig polypeptides
BRISTOL MYERS SQUIBB CO0 citations52
US10370428B2Aug 6, 2019
Methods of treatment using CTLA4 mutant molecules
BRISTOL MYERS SQUIBB CO0 citations51
US9399052B2Jul 26, 2016
Polynucleotides encoding BSL2v2c2-Ig
BRISTOL MYERS SQUIBB CO0 citations50
COHEN ROBERT
3 patentsUS8497247B2Jul 30, 2013
Methods for treating type I diabetes mellitus by administering a soluble CTLA4 molecule
COHEN ROBERT15 citations91
US8227420B2Jul 24, 2012
Method for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID
COHEN ROBERT10 citations91
US8148332B2Apr 3, 2012
Method for treating a rheumatic disease using a soluble TLA4 molecule
COHEN ROBERT9 citations91